Skip to main content
Research

Research Activity Assumptions

The research activity is supported by the following assumptions:

  • Registration in the National Research Registry, art. 64, paragraph 1, Presidential Decree 11 July 1980 n° 382 with communication of 29.10.2012 prot. 238\343 of the Ministry of Education, University and Research
  • Recognition as an “Outpatient Center for clinical trials of phase II and III drugs, for patients only, excluding healthy volunteers, pregnant women and subjects under 18 years of age” with Resolution No. 1220 of 09.09.2014 of ASL Milano and subsequent inclusion in the AIFA list of Centers Authorized to conduct “Clinical pharmacological trials”; confirmation by ATS Milano with resolution of 7.08.2018
  • Recognition dated 01.04.2015 with DGR X/3350 as a Presidium of the Regional Network for Rare Diseases, for the pathologies Amyotrophic Lateral Sclerosis, Primary Lateral Sclerosis and Chronic Inflammatory Demyelinating Polyneuropathy
  • Company validation by the European Commission Research Executive Agency (REA) and confirmation of the PIC (Personal Identification Code)
  • With regard to the approval of research projects, the Structure has been responsible, since 6 June 2013, for the Ethics Committee of Milan Area 2, Reference Structure: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
  • Recognition of inclusion in the Lombardy District for Biomedical Innovation, Decree of the Central Directorate for Integrated Programming of the Lombardy Region, n°5981 of 5.7.2012, to which regional, national and European funds refer
  • Adhesion on 05/01/2015 to the Life Sciences Cluster, a tool for enhancing and relaunching the Life Sciences (LS) sector in Lombardy in terms of competitiveness
  • Registration in the Questio system (Quality Evaluation in Science and Technology for Innovation Opportunity) for the year 2018, which represents the mapping of the Research and Innovation Centers (CRTT) in the Lombardy Region, whose presence is an essential condition for participation in calls for proposals sent by the Region and the Ministry of Health
  • Recognition by the Lombardy Region on 24.02.2017, as a Center for Cognitive Disorders and Dementia (CDCD) and inclusion in the online Map of dementia services available through the Dementia Observatory website (www.iss.it/demenze), entirely dedicated to dementia within the ISS portal and with a direct link to the Ministry of Health website
  • Recognition as a Prescribing Center for drugs referred to in AIFA NOTE 79, from March 2016, with the authorization to prescribe therapeutic plans on a specific AIFA Platform
  • Recognition as an Authorized Center for the drafting of the Therapeutic Plan for anticholinesterase drugs, from 30.11.2015, pursuant to AIFA Note 85.